Trustees of Columbia University in the City of New York Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sana Biotechnology
SANA
|
+$529K |
| 2 |
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
|
+$260K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$6.55M |
| 2 |
CFLT
Confluent
CFLT
|
+$4.6M |
| 3 |
Disc Medicine
IRON
|
+$1.59M |
| 4 |
Kanzhun
BZ
|
+$1.24M |
| 5 |
Progyny
PGNY
|
+$470K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 75.04% |
| 2 | Healthcare | 15.01% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Consumer Staples | 0.49% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.08T
| $40.4M | 74.33% |
76
| – | – |
|
|
2
Airbnb
ABNB
$109B
| $4.87M | 8.96% |
35,487
-47,460
| -57% | -$6.55M |
|
|
3
Disc Medicine
IRON
$3.06B
| $3.7M | 6.8% |
78,682
-31,806
| -29% | -$1.59M |
|
|
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
| $1.22M | 2.24% |
9,173
| – | – |
|
|
VIGL
5
DELISTED
Vigil Neuroscience
VIGL
| $1.04M | 1.91% |
192,973
| – | – |
|
6
Tenaya Therapeutics
TNYA
$168M
| $744K | 1.37% |
291,828
| – | – |
|
7
Xilio Therapeutics
XLO
$59.8M
| $527K | 0.97% |
17,831
| – | – |
|
|
8
Berkshire Hathaway Class B
BRK.B
$1.09T
| $385K | 0.71% |
1,100
| – | – |
|
|
9
Sana Biotechnology
SANA
$1.1B
| $381K | 0.7% |
+98,353
| New | +$529K |
|
10
Surrozen
SRZN
$283M
| $352K | 0.65% |
47,930
| – | – |
|
|
ROVR
11
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $273K | 0.5% |
+43,607
| New | +$260K |
|
12
Coursera
COUR
$1.49B
| $265K | 0.49% |
14,188
-1,522
| -10% | -$24.3K |
|
13
Vor Biopharma
VOR
$1.36B
| $195K | 0.36% |
4,596
| – | – |
|
|
SRZNW
14
DELISTED
Surrozen Inc Warrant
SRZNW
| $1.37K | ﹤0.01% |
33,333
| – | – |
|
15
Amplitude
AMPL
$1.55B
| – | – |
-18,944
| Closed | -$208K |
|
|
16
Kanzhun
BZ
$6.91B
| – | – |
-82,083
| Closed | -$1.24M |
|
|
CFLT
17
DELISTED
Confluent
CFLT
| – | – |
-130,383
| Closed | -$4.6M |
|
|
18
Progyny
PGNY
$2B
| – | – |
-11,943
| Closed | -$470K |
|
Similar funds
Trustees of Columbia University in the City of New York's Q3 2023 Portfolio in Review
As of Q3 2023, Trustees of Columbia University in the City of New York held 18 positions worth $54.3M, down 20% from $68.2M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Trustees of Columbia University in the City of New York withdrew a net $13.9M in Q3 2023, closing 4 positions and reducing 3 holdings. Its most notable exit was Confluent, an estimated $4.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 75% of assets, up from 58% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Trustees of Columbia University in the City of New York opened a new position in Sana Biotechnology worth $381K.
- Trustees of Columbia University in the City of New York's largest Q3 2023 buy was Sana Biotechnology: 98,353 shares worth $381K.
- Trustees of Columbia University in the City of New York's biggest Q3 2023 reduction was Airbnb, cutting an estimated $6.55M.
- Trustees of Columbia University in the City of New York fully exited Confluent in Q3 2023, selling an estimated $4.6M.
- Trustees of Columbia University in the City of New York's ten largest holdings make up 99% of its $54.3M portfolio in Q3 2023.
- Trustees of Columbia University in the City of New York opened 2 new positions and closed 4 in Q3 2023.
- Trustees of Columbia University in the City of New York's portfolio value fell 20% quarter-over-quarter to $54.3M.
Based on Trustees of Columbia University in the City of New York's 13F filing for Q3 2023, filed 14 Nov 2023.